通过IQGAP3信号调解内功能异质性,以增强恶性生长
Mitsuhiro Shimura1,2, Junichi Matsuo1, ShuChin Pang1
1Cancer Science Institute of Singapore, National University of Singapore, Singapore.
Gut
|October 22, 2024
概括
IQGAP3通过维持细胞多样性和促进RAS-TGFβ信号传递来驱动胃癌的生长. 抑制IQGAP3可以减少瘤生长和转移,突出显示其作为治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 在各种癌症中,IQ5013 (IQGAP3) 表达升高,这表明它在致癌过程中发挥了作用.
- IQ5013是胃干细胞增殖和RAS-ERK通路调节的已知因素,但其在癌症进展中的确切作用尚不清楚.
研究的目的:
- 阐明IQ5013在胃癌 (GC) 发育和进展中的作用.
主要方法:
- 用IQ5013敲击对GC细胞系的RNA测序来分析表型变化.
- 在体内瘤发生和肺转移的测试证实了IQ5013在瘤信号传递中的作用.
- 空间分析以评估内转录和功能差异.
主要成果:
- 通过阻断酸化,IQ5013抑制减弱了KRAS信号通路.
- 降低IQ5013降低了与MEK/ERK信号相关的生长因子 (例如,TGFβ1),损害了瘤微环境的形成,并降低了转移潜力.
- 具有IQ5013敲击细胞的异体移植显示出瘤发生和肺转移的减少;观察到TGFβ/SMAD信号传导和树皮细胞标记的减少.
- 数字空间分析证实IQ5013的必要性形成不同的细胞亚群,促进致癌功能.
结论:
- IQ5013敲击抑制了RAS-TGFβ信号交叉声,减少了瘤的微环境.
- IQ5013对于维持癌细胞异质性至关重要,从而增强恶性生长.
- IQ5013代表了胃癌的重要治疗标.
更多相关视频
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.3K
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
9.0K
相关概念视频
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K